SUVZ.US Suvanza Pharma LLC

Healthcare Biotechnology USA Stocks
- USD
Market cap
-
P/E
-
P/B
0.35x
ROE
-254.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2003.

Is SUVZ.US undervalued?

Graham number

The Graham number of Suvanza Pharma LLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Suvanza Pharma LLC fundamental analysis

No fundamental analysis for Suvanza Pharma LLC yet.

Suvanza Pharma LLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Suvanza Pharma LLC

Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.

Full company profile